Renaissance Technologies
FEED

Renaissance Technologies’s ENvue Medical Inc FEED Stock Holding History

Renaissance Technologies’s Portfolio FEED Stock Details FEED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-242
Closed -$16.3K – 3784
2024
Q3 		$16.3K Buy
242
+46
+23% +$3.35K ﹤0.01% 3439
2024
Q2 		$15.1K Sell
196
-157
-44% -$13.4K ﹤0.01% 3405
2024
Q1 		$35K Sell
353
-22
-6% -$2.38K ﹤0.01% 3535
2023
Q4 		$47K Buy
+375
New +$46K ﹤0.01% 3466
2022
Q4 		– Sell
-14
Closed -$14K – 4303
2022
Q3 		$14K Sell
14
-43
-75% -$56.1K ﹤0.01% 3931
2022
Q2 		$79K Sell
57
-77
-57% -$121K ﹤0.01% 3903
2022
Q1 		$341K Sell
134
-24
-15% -$45.3K ﹤0.01% 3410
2021
Q4 		$361K Buy
+158
New +$470K ﹤0.01% 3255
2021
Q3 		– Sell
-39
Closed -$73K – 3713
2021
Q2 		$73K Sell
39
-106
-73% -$214K ﹤0.01% 3379
2021
Q1 		$325K Sell
145
-88
-38% -$225K ﹤0.01% 3039
2020
Q4 		$392K Buy
+233
New +$381K ﹤0.01% 2926

Other funds holding FEED

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies's FEED Position: Q4 2024 in Review

Renaissance Technologies sold out of ENvue Medical Inc (FEED) in Q4 2024, closing a stake of 242 shares — an estimated $16.3K sold.

Renaissance Technologies first reported a position in FEED in Q4 2020 and held it in 11 quarters. The position peaked at $392K in Q4 2020. 8 funds tracked by Wall St. Rank hold FEED as of Q4 2024.

  • Renaissance Technologies reported no remaining ENvue Medical Inc position as of Q4 2024 after selling out during the quarter.
  • Renaissance Technologies sold 242 ENvue Medical Inc shares in Q4 2024, an estimated $16.3K.
  • Renaissance Technologies first reported a position in ENvue Medical Inc in Q4 2020 and held it in 11 quarters.
  • Renaissance Technologies's ENvue Medical Inc position peaked at $392K in Q4 2020.
  • 8 funds tracked by Wall St. Rank held ENvue Medical Inc as of Q4 2024.

Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.